Advanced search
Publication Cover
International Journal of Radiation Biology Volume 85, 2009 - Issue 11: Special Issue: Papers presented at the 2nd workshop on Radiation and Multidrug Resistance mediated via the Tumour-Microenvironment. Guest Editors: Nils Cordes and Mary Helen Barcellos-Hoff
Submit an article Journal homepage
221
Views
33
CrossRef citations to date
0
Altmetric
Papers Presented at the 2nd Workshop on Radiation and Multidrug Resistance Mediated via the Tumour-Microenvironment

Heterogeneity of tumour response to combined radiotherapy and EGFR inhibitors: Differences between antibodies and TK inhibitors

Mechthild Krause;Department of Radiation Oncology, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität DresdenCorrespondence[email protected]
,
Kristin Gurtner;OncoRay Center for Radiation Research in Oncology, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden
,
Yvonne Deuse;Experimental Center, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany
&
Michael Baumann;Department of Radiation Oncology, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden
Pages 943-954 | Received 31 Mar 2009, Accepted 16 Jul 2009, Published online: 06 Nov 2009

Citations (33)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ingrid Fumagalli, Delphine Dugue, Jean Emmanuel Bibault, Céline Clémenson, Marie Catherine Vozenin, Michele Mondini & Eric Deutsch. (2015) Cytotoxic effect of lapatinib is restricted to human papillomavirus-positive head and neck squamous cell carcinoma cell lines. OncoTargets and Therapy 8, pages 335-345.
Read now

Articles from other publishers (32)

Yangyang Kong, Chang Xu, Xiaohui Sun, Hao Sun, Xiaotong Zhao, Ningning He, Kaihua Ji, Qin Wang, Liqing Du, Jinhan Wang, Manman Zhang, Yang Liu, Yan Wang & Qiang Liu. (2022) BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair. Cancer Biology & Medicine 19:8, pages 1150-1171.
Crossref
Iris Eke, Molykutty J. Aryankalayil, Michelle A. Bylicky, Adeola Y. Makinde, Lance Liotta, Valerie Calvert, Emanuel F. Petricoin, Edward E. Graves & C. Norman Coleman. (2022) Radiotherapy alters expression of molecular targets in prostate cancer in a fractionation- and time-dependent manner. Scientific Reports 12:1.
Crossref
Venkata S. K. Manem. (2021) Development and validation of genomic predictors of radiation sensitivity using preclinical data. BMC Cancer 21:1.
Crossref
Annarita Perillo, Mohamed Vincenzo Agbaje Olufemi, Jacopo De Robbio, Rossella Margherita Mancuso, Anna Roscigno, Maddalena Tirozzi & Ida Rosalia Scognamiglio. (2021) Liquid biopsy in NSCLC: a new challenge in radiation therapy. Exploration of Targeted Anti-tumor Therapy.
Crossref
Karolin Schneider, Nadja Ebert, Ina Kurth & Michael Baumann. 2020. Molecular Targeted Radiosensitizers. Molecular Targeted Radiosensitizers 137 159 .
Kurian Joseph, Khalifa Alkaabi, Heather Warkentin, Sunita Ghosh, Naresh Jha, Michael Smylie & John Walker. (2018) Cetuximab‐radiotherapy combination in the management of locally advanced cutaneous squamous cell carcinoma. Journal of Medical Imaging and Radiation Oncology 63:2, pages 257-263.
Crossref
In Ho Song, Youn Noh, Junhye Kwon, Jae Ho Jung, Byung Chul Lee, Kwang Il Kim, Yong Jin Lee, Joo Hyun Kang, Chae Seo Rhee, Chul Hee Lee, Tae Sup Lee & Ik Joon Choi. (2017) Immuno-PET imaging based radioimmunotherapy in head and neck squamous cell carcinoma model. Oncotarget 8:54, pages 92090-92105.
Crossref
Lydia Koi, Steffen Löck, Annett Linge, Cedric Thurow, Sandra Hering, Michael Baumann, Mechthild Krause & Kristin Gurtner. (2017) EGFR-amplification plus gene expression profiling predicts response to combined radiotherapy with EGFR-inhibition: A preclinical trial in 10 HNSCC-tumour-xenograft models. Radiotherapy and Oncology 124:3, pages 496-503.
Crossref
Ariana Rostami & Scott V. Bratman. (2017) Utilizing circulating tumour DNA in radiation oncology. Radiotherapy and Oncology 124:3, pages 357-364.
Crossref
Dominik Thomas Koch, Anja Pickhard, Lena Gebel, Anna Maria S. Buchberger, Murat Bas, Carolin Mogler, Rudolf Reiter, Guido Piontek & Markus Wirth. (2017) Epidermal growth factor receptor variant III in head and neck squamous cell carcinoma is not relevant for targeted therapy and irradiation. Oncotarget 8:20, pages 32668-32682.
Crossref
Michael Baumann, Mechthild Krause, Jens Overgaard, Jürgen Debus, Søren M. Bentzen, Juliane Daartz, Christian Richter, Daniel Zips & Thomas Bortfeld. (2016) Radiation oncology in the era of precision medicine. Nature Reviews Cancer 16:4, pages 234-249.
Crossref
Iris Eke, Katja Zscheppang, Ellen Dickreuter, Linda Hickmann, Ercole Mazzeo, Kristian Unger, Mechthild Krause & Nils Cordes. (2015) Simultaneous β1 integrin-EGFR Targeting and Radiosensitization of Human Head and Neck Cancer. JNCI: Journal of the National Cancer Institute 107:2.
Crossref
Kristin Gurtner, Nadja Ebert, Dorothee Pfitzmann, Wolfgang Eicheler, Daniel Zips, Michael Baumann & Mechthild Krause. (2014) Effect of combined irradiation and EGFR/Erb-B inhibition with BIBW 2992 on proliferation and tumour cure in cell lines and xenografts. Radiation Oncology 9:1.
Crossref
Sara Falivene, Francesca Maria Giugliano, Antonio Maria Grimaldi, Rossella Di Franco, Diego Toledo, Matteo Muto, Fabrizio Cammarota, Valentina Borzillo, Paolo Antonio Ascierto & Paolo Muto. (2014) Tomotherapy concomitant with cetuximab, followed by cetuximab as single-agent therapy for unresectable squamous cell carcinoma of the skin: a case report. BMC Dermatology 14:1.
Crossref
Falk Tillner, Prasad Thute, Rebecca Bütof, Mechthild Krause & Wolfgang Enghardt. (2014) Pre-clinical research in small animals using radiotherapy technology – a bidirectional translational approach. Zeitschrift für Medizinische Physik 24:4, pages 335-351.
Crossref
Aleksandra Gruca, Zdzisław Krawczyk, Wiesław Szeja, Grzegorz Grynkiewicz & Aleksandra Rusin. (2014) Synthetic Genistein Glycosides Inhibiting EGFR Phosphorylation Enhance the Effect of Radiation in HCT 116 Colon Cancer Cells. Molecules 19:11, pages 18558-18573.
Crossref
K. Zarschler, K. Prapainop, E. Mahon, L. Rocks, M. Bramini, P. M. Kelly, H. Stephan & K. A. Dawson. (2014) Diagnostic nanoparticle targeting of the EGF-receptor in complex biological conditions using single-domain antibodies. Nanoscale 6:11, pages 6046-6056.
Crossref
Min-Jung Kim, Hong Shik Yun, Eun-Hee Hong, Su-Jae Lee, Jeong-Hwa Baek, Chang-Woo Lee, Ji-Hye Yim, Jae-Sung Kim, Jong Kuk Park, Hong-Duck Um & Sang-Gu Hwang. (2013) Depletion of end-binding protein 1 (EB1) promotes apoptosis of human non-small-cell lung cancer cells via reactive oxygen species and Bax-mediated mitochondrial dysfunction. Cancer Letters 339:1, pages 15-24.
Crossref
Mechthild Krause. (2013) Epidermal growth factor receptor targeting and its role for individualisation in radiation oncology. European Journal of Cancer Supplements 11:2, pages 274.
Crossref
Orit Kaidar-Person, Christine Lai, Abraham Kuten & Yazid Belkacemi. (2013) “The Infinite Maze” of breast cancer, signaling pathways and radioresistance. The Breast 22:4, pages 411-418.
Crossref
Yu-Chieh Tsai, Chih-Hsien Yeh, Kai-Yuan Tzen, Pei-Yin Ho, Tsung-Fan Tuan, Yeong-Shiau Pu, Ann-Lii Cheng & Jason Chia-Hsien Cheng. (2013) Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma. European Journal of Cancer 49:6, pages 1458-1466.
Crossref
M. Baumann, D. Zips & M. Krause. (2012) Experimentelle TumortherapieExperimental tumor therapy. Strahlentherapie und Onkologie 188:S3, pages 291-294.
Crossref
M. Saki, M. Toulany, W. Sihver, M. Zenker, J.-M. Heldt, B. Mosch, H.-J. Pietzsch, M. Baumann, J. Steinbach & H.P. Rodemann. (2012) Cellular and molecular properties of 90Y-labeled cetuximab in combination with radiotherapy on human tumor cells in vitroZelluläre und molekulare Eigenschaften von 90Y-markiertem Cetuximab in Kombination mit Strahlentherapie bei humanen Tumorzellen in vitro. Strahlentherapie und Onkologie 188:9, pages 823-832.
Crossref
Iris Eke, Yvonne Deuse, Stephanie Hehlgans, Kristin Gurtner, Mechthild Krause, Michael Baumann, Anna Shevchenko, Veit Sandfort & Nils Cordes. (2012) β1 Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy. Journal of Clinical Investigation 122:4, pages 1529-1540.
Crossref
Ala Yaromina, Mechthild Krause & Michael Baumann. (2012) Individualization of cancer treatment from radiotherapy perspective. Molecular Oncology 6:2, pages 211-221.
Crossref
Kristin Gurtner, Franziska Hessel, Wolfgang Eicheler, Annegret Dörfler, Daniel Zips, Karl-Heinz Heider, Mechthild Krause & Michael Baumann. (2012) Combined treatment of the immunoconjugate bivatuzumab mertansine and fractionated irradiation improves local tumour control in vivo. Radiotherapy and Oncology 102:3, pages 444-449.
Crossref
Maximilian Niyazi, Cornelius Maihoefer, Mechthild Krause, Claus Rödel, Wilfried Budach & Claus Belka. (2011) Radiotherapy and "new" drugs-new side effects?. Radiation Oncology 6:1.
Crossref
Kristin Gurtner, Yvonne Deuse, Rebecca Bütof, Katja Schaal, Wolfgang Eicheler, Reinhard Oertel, Reidar Grenman, Howard Thames, Ala Yaromina, Michael Baumann & Mechthild Krause. (2011) Diverse effects of combined radiotherapy and EGFR inhibition with antibodies or TK inhibitors on local tumour control and correlation with EGFR gene expression. Radiotherapy and Oncology 99:3, pages 323-330.
Crossref
Adrian C. Begg, Fiona A. Stewart & Conchita Vens. (2011) Strategies to improve radiotherapy with targeted drugs. Nature Reviews Cancer 11:4, pages 239-253.
Crossref
Marika Nestor, Magnus Sundström, Matti Anniko & Vladimir Tolmachev. (2011) Effect of cetuximab in combination with alpha-radioimmunotherapy in cultured squamous cell carcinomas. Nuclear Medicine and Biology 38:1, pages 103-112.
Crossref
Emily J. Noonan, Robert F. Place & Long-Cheng Li. 2011. MicroRNAs in Cancer Translational Research. MicroRNAs in Cancer Translational Research 415 447 .
Alina Santiago, Wolfgang Eicheler, Jan Bussink, Paul Rijken, Ala Yaromina, Bettina Beuthien-Baumann, Albert J. van der Kogel, Michael Baumann & Mechthild Krause. (2010) Effect of cetuximab and fractionated irradiation on tumour micro-environment. Radiotherapy and Oncology 97:2, pages 322-329.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.